News

2021/09/09
Gemseki Ventures L.P. is pleased to announce our investment in PRISM BioLab. PRISM BioLab has a drug discovery platform…
2021/07/28
Our VP of Business Development, Sanjeev Balhara, made a presentation of “Accelerating Global Pharma Licensing and…
2021/06/01
Gemseki Ventures L.P. is pleased to announce our investment in Curreio. Curreio is a Tokyo-based biotech startup that…
2021/03/01
Gemseki Ventures L.P. is pleased to announce our first investment, acquiring shares from Cardio Intelligence, a Tokyo-…
2021/02/26
We are thrilled to announce that, with Gemseki’s assistance to Harvard University’s Office of Technology Development (…
2021/02/03
 Gemseki hereby announces the appointment of Dr. Ichiro Nagata as President and CEO of Gemseki Inc. as of February 3,…
2020/10/23
Hideyuki Hirama, the President and CEO of Gemseki, made a presentation of “Key Points to Commercialize Drug Candidates…
2020/10/21
We are pleased to announce our business expansion to investment and incubation and the launch of Gemseki Ventures, L.P…
2020/10/08
We are pleased to announce our partnership with Industrial Technology Research Institute (ITRI), the biggest applied…
2020/10/02
We are pleased to inform you that Gemseki has participated in the Sustainable Development Goals (SDGs) for Regional…